Crossmark

Economics, efficacy and safety of five traditional Chinese medicine injections plus chemotherapy as adjuvant therapy for non-small cell lung cancer: A network meta-analysis

Crossref DOI link: https://doi.org/10.1007/s11096-025-02035-6

Published Online: 2025-10-30

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Kai

Li, Hongtao

Zhu, Yulu

Jing, Zhuying

Gao, Lihong

Sun, Yuyang

Ding, Baolong

Yao, Hongting

Wang, Hui

Li, Xin https://orcid.org/0000-0003-3951-8061
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (72074123)
License Information

Text and Data Mining valid from 2025-10-30

Version of Record valid from 2025-10-30
More Information

Article History

Received: 26 August 2025

Accepted: 11 October 2025

First Online: 30 October 2025

Declarations

:

: The authors declare that they have no conflicts of interest.

: Not applicable, as there were no human participants involved in this study.

Document is current

Any future updates will be listed below